chronic

Failure to Thrive (Faltering Growth in Infants)

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

Egyptian National Drug Formulary - Blood Disorder Medications 2025 (ferrous fumarate monograph) · NICE Guideline NG75: Faltering growth 2017 · WHO Child Growth Standards Guidance

Verified against2 documents

Egyptian National Drug Formulary - Blood Disorder Medications 2025 (ferrous fumarate monograph)
Failure to Thrive - disease-level clinical article (failure-to-thrive-infant-clinical.txt)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (8)

Parents may report feeding refusal, texture preferences, trouble swallowing, gagging, belly pain, or vomiting with feeds [abdominal pain · difficulty swallowing · vomiting]
Warning signs include blood or mucus in stool, bulky foul-smelling stools, or new nighttime stool urgency or leakage in a previously toilet-trained child
A history of prematurity, being small for gestational age, low blood sugar, or jaundice at birth is relevant [hypoglycaemia · jaundice]
Fast breathing, tiring, or sweating during feeds can point to an underlying heart problem [sweating · tachypnoea]
A falling weight percentile worries more than a child who has always tracked low and may simply be meeting their own growth potential
Red flag: untreated it ends in stunted growth, and it is associated with developmental delay and other long-term effects on a developing child [developmental delay · stunted growth]
The effect on the brain is worst in children under 2 and when the malnutrition has run longer
It has been linked to a lower IQ, to ADHD and learning difficulty, and to impaired communication [learning difficulty]

Signs — what you find (3)

Exam may reveal dysmorphic features, oral-motor problems, thyroid nodules or goiter, a heart murmur, fast breathing, lung findings, or an abdominal mass or enlarged organ [abdominal mass · dysmorphic features · goitre · heart murmur · tachypnoea]
Often the only exam finding is poor weight gain and a thin build, without any other clue to a specific cause [failure to thrive]
Actual weight loss since the last visit is a red flag, since a normally thriving child should not lose weight [weight loss]

Tests (10)

Malnutrition severity is graded by weight-for-length z-score: -1 to -1.9 mild, -2 to -2.9 moderate, and below -3 severe
First-line labs are a CBC to check for anemia, an iron panel since iron deficiency is the most common type at this age, and a metabolic panel for hydration and organ function
When refeeding syndrome is a risk, phosphorus and magnesium levels are added to the standard metabolic panel
An ESR can flag nonspecific underlying inflammation
Thyroid function is checked with TSH and free T4
Urinalysis and urine culture screen for kidney disease and a common chronic infection
Stool studies including culture, occult blood, fecal calprotectin, and reducing substances are sent for abnormal stool patterns
A celiac panel with tissue transglutaminase IgA and total IgA is checked for GI symptoms
The consensus definition is a weight for age below the fifth percentile, a drop of more than 2 major percentile lines, or under 80% of the median weight for height
For a baby born early, correct the growth percentile for gestational age until the child is 2 years old

If not this — what else fits (4)

Primary short stature, defined by a height z-score of -2 or below, is a key alternative diagnosis to weight-based failure to thrive
Growth hormone deficiency, constitutional delay, familial short stature, and idiopathic short stature can all cause isolated short stature
Cushing syndrome, thyroid dysfunction, and hypopituitarism can all present with poor linear growth
Long-term systemic steroid use is an iatrogenic cause of poor growth to consider

SourceStatPearls "Failure to Thrive" - disease-level clinical article

Presentation findings are traced to the source above.

MULTIVITAMIN + IRON

1st line

Formoral.liquid

Adult dose and duration

Not applicable - pediatric entry x 3-6 months under growth monitoring

Paediatric dose

Only where iron deficiency is identified. Egyptian formulary paediatric dose: ferrous fumarate 140 mg/5 mL syrup 0.5 mL/kg/day in 2-3 divided doses, maximum 20 mL a day - that is 4.5 mg/kg/day of elemental iron, ceiling 180 mg. Premature infants up to 3 kg: 0.5 mL a day.

Dose source

Egyptian National Drug Formulary - Blood Disorder Medications 2025 (ferrous fumarate monograph)

Why

Iron replacement where the iron panel shows deficiency, the commonest micronutrient deficiency at this age, while the calorie deficit and any organic cause are investigated. The iron figure is the Egyptian formulary's; no guideline states a dose for the multivitamin half of a combination syrup.

Cautions

PRIMARY CARE ROLE: Perform detailed feeding history, observe feeding session, calculate caloric density.
The red flags requiring urgent pediatric referral are organomegaly, dysmorphic features, developmental regression, severe anemia, and abnormal urinalysis.
Do not rely solely on vitamin supplements without addressing caloric deficit and psychosocial factors.
Dose a combination multivitamin+iron syrup by the elemental iron its carton states, not by the volume above - the figure here is the formulary's ferrous fumarate syrup. No guideline doses the vitamin component for faltering growth; give it per its own product label.

Egyptian brands

Egyptian brand	Manufacturer	Indicative price
FERNISAL 120 ML SYR	ORGANIX > SALUS PHARMACEUTICAL	75.00 EGP

REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)

1st line

Dose source

Failure to Thrive - disease-level clinical article (failure-to-thrive-infant-clinical.txt)

Why

Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen.

Cautions

RED FLAG - The hospitalization criteria are severe malnutrition, dehydration, suspected abuse or neglect, and failed outpatient management.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.